Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · September 26, 2024

Prevalence of Type I IFNs in Plasma and Saliva of Patients With COVID-19 and Association With Clinical Outcomes

Heart & Lung

 

Additional Info

Heart & Lung
Salivary autoantibodies to type I IFNs: Mirror plasma levels, predispose to severe COVID-19, and enhance feasibility for clinical screening
Heart Lung 2024 Sep 01;66(xx)31-36, N Saheb Sharif-Askari, F Saheb Sharif-Askari, OS Bayram, S Hafezi, HAH Alsayed, F Kasim, B Mdkhana, B Selvakumar, HS Alsafar, R Halwani

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading